Key facts
- This page summarizes Sivan Scherf-Siboni's Form 3 filing for Foresight Autonomous Holdings Ltd. (FRSX).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 30 Mar 2026, 17:28.
Sivan Scherf-Siboni - 18 Mar 2026 Form 3 Insider Report for Foresight Autonomous Holdings Ltd. (FRSX)
- Reporting relationship
- VP of Human Resources
- Issuer ticker
- FRSX
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Sivan Siboni-Scherf
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Sivan Scherf-Siboni filed Form 3 for Foresight Autonomous Holdings Ltd. (FRSX) on 30 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001966285
Primary reporting owner
Scherf-Siboni Sivan
- Relationship
- VP of Human Resources
- Address
- C/O FORESIGHT AUTONOMOUS, 7 GOLDA MEIR ISRAEL, NESS ZIONA, ISRAEL
- Signature
- /s/ Sivan Siboni-Scherf
- Signature date
- 30 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FRSX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,257,143
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
FRSX
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 150,000
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FRSX
holding
Derivative
American Depositary Receipts
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 107,100
- Exercise price
- Footnotes
- F4
FRSX
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 21,429
- Exercise price
- $1.12
- Footnotes
- F5, F6
FRSX
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 100,000
- Exercise price
- $1.12
- Footnotes
- F5, F7
FRSX
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 85,714
- Exercise price
- $1.12
- Footnotes
- F5, F8
FRSX
holding
Derivative
Stock options (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- See Footnote
- Underlying class
- Ordinary Shares
- Underlying amount
- 57,143
- Exercise price
- $1.12
- Footnotes
- F3, F5, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
Includes 1,128,571 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through January 1, 2029.Each RSU represents the right to receive one Ordinary Share.
Footnote F2
Includes 75,000 Ordinary Shares issuable upon the vesting of RSUs through July 1, 2027.
Footnote F3
The securities are owned by Moshe Scherf, Mrs. Siboni Scherf's spouse, and, therefore, Mrs. Siboni Scherf may be deemed to beneficially own securities owned by Mr. Scherf, to the extent of her spouse's pecuniary interest therein. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
Footnote F4
The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.
Footnote F5
The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.
Footnote F6
The options were granted on May 4, 2017 and fully vested as of January 1, 2020.
Footnote F7
The options were granted on July 16, 2020 and fully vested as of December 31, 2022.
Footnote F8
The options were granted on October 20, 2022 and fully vested as of December 31, 2025.
Footnote F9
The options were granted on October 20, 2022 and fully vested as of September 30, 2025.